---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-25-000013"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T04:12:46.275009+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific subsidiary prices €1.5B senior notes to refinance 2025 maturity

## Summary
- AMS Europe issued €850M 3.000% notes due 2031 and €650M 3.250% notes due 2034.
- Net proceeds of approximately €1.487B after underwriting discount and expenses.
- Proceeds will fund repayment of AMS Europe's 0.750% notes due March 8, 2025.
- Remaining proceeds for general corporate purposes including acquisitions.
- Notes are fully and unconditionally guaranteed by Boston Scientific.

## SEC filing metadata
- accession: 0000885725-25-000013
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572525000013/0000885725-25-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572525000013/bsx-20250221.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-25-000013
- JSON: https://secwatch.observer/filing/0000885725-25-000013.json
- Plain text: https://secwatch.observer/filing/0000885725-25-000013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.